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Physiological biokinetic model for plutonium
Various approaches are possible individually or in combinations to develop a physiological biokinetic
model for a radioactive substance, such as plutonium:
1. Comparison and optimization of an existing biokinetic model under physiological aspects
(WG 7.3 “Towards a new DTPA treatment model”, since 2007).
2. Creation of a physiological biokinetic model based on a central compartment and including 
physiological facts and transfer rates. (Self-made or pharmacokinetic model, ISF (FzK/KIT) 
since 2007)
3. Assessment of biokinetic developments after incorporation of plutonium in analogy with biokinetics or 
pharmacokinetics of a substance showing comparable chemical and physiological behavior in the 
body. (WG 7.2 “Development and QA of Biokinetic Models”, since today)
The quality of the resulting models depends on how accurately their assumptions reflect reality. 
Ideally, a biokinetic model develops which reproduces reality.
Ideally, the three approaches result in similar or even identical compartment structures in a biokinetic
model reflecting reality. 
Schimmelpfeng, J.: Physiology-based modelling in radiation research – The biokinetics of Plutonium. 
Radiation Protection Dosimetry 136, 74-81, 2009.
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Physiological biokinetic model for plutonium
Assumption 1: Plutonium can be 
incorporated by injection, ingestion, a 
wound (invulneration) or inhalation. 
Assumption 2: Plutonium occurs in 
compounds of oxidation levels +III to +VII. 
Mammalian fluids, such as blood plasma, 
urine and tissue fluids are dominated by 
Pu(IV) because most endogenous ligands
stabilize this state of oxidation.
Assumption 3: The similarities of the 
chemical and biological transport and 
distribution properties of Fe(III) and Pu(IV)
are remarkable. Plutonium is transported 
in the body in a similar way as iron.
* Ansoborlo E, Bion L, Doizi D, Moulin C, Lourenco V, Madic C, Cote G, Van der Lee J, Moulin V. Current and future 
radionuclide speciation studies in biological media. Radiat Prot Dosimetry. 2007;127(1-4):97-102. Epub 2007 Jun 19. 
log K(Pu(IV)-ligand) / log K(Fe(III)-ligand) ~ (1 : 1)
*
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Assumption 4: Fe3+ and Al3+ ions also 
show chemical similarity with respect to 
equivalent binding behavior. 
Assumption 5: Major reaction partners
are transferrin and citrate in the blood 
and in the extracellular fluid. That applies 
to plutonium and to aluminium. 
“The radius of Al3+ most resembles that 
of Fe3+ (Martin 1986). Thus appearance 
of Al3+ in Fe3+ sites seems likely.”
„Aluminium will follow many of the
metabolic pathways that exist for iron.
This linkage is well established (Priest, 
2004).“
„Martin also suggests that, based on 
consideration of stability constants
plasma aluminium will bind to both
transferrin and citrate“.
Conclusion: The similarities of the chemical and biological transport and distribution properties of 
Fe(III), Al(III) and Pu(IV) are remarkable. 
Why not use them to create a physiological biokinetik model for plutonium.
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* Nolte, E., Beck, E., Winklhofer, C., and Steinhausen, C.: Compartmental model for aluminium biokinetics. 
Human & Experimental Toxicology  20, 111-117 (2001).
Figure 2. Pharmacokinetic model for aluminium *.
The central compartment is made up of aluminium
bound to transferrin (T) and citrate (C) in plasma (P) 
and the interstitial fluid (I). 
From this central compartment (PT, PC, IT, and IC) 
the aluminium is distributed into the peripheral 
compartments, P1 (liver and spleen), P2 
(muscles), and P3 (bones). 
The gastro-intestinal tract is subdivided into the 
stomach (M), the duodenum (D), and the rest of the 
digestive tract (R). 
Transport among the compartment sections is 
described by rate constants which are inverse time 
constants. The time constants are added to the 
arrows describing transport. 
The urine excretion time is TU. 
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Figure 3. Basic physiological-based compartment model *
for the biokinetics of plutonium. 
This model is based on conclusion by analogy, 
precisely because Pu(VI), Fe(III) and Al(III) show 
comparable chemical and physiological behavior in the 
body. 
Relevant chemical reactions are modeled in their 
anatomical structures.
Transport rate and time constants between the 
compartments might be similar to those in figure 2.
* Schimmelpfeng, J.: Physiology-based modelling in radiation research 
– The biokinetics of Plutonium. Radiation Protection Dosimetry 136 (2), 74-81, 2009.
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Proposal of new action (Dietmar, Jutta):
1. Refine the new physiological model, if necessary (e.g. skeleton/bones: Andrea?, all)
2. Test the new physiological model (with data from the literature and from USTUR: all)
3. Validation by comparing simulation and published experimental kinetic data (all)
4. Further experiments needed? (all)
5. Comparison with present models, e.g. Leggett et al. 2005 (all)
6. Development of a final physiological model and discussion of its reliability and applicability (all)
Physiological biokinetic model for plutonium
Figure 4. Biokinetic compartment model for aluminium, 
modified after Priest et al. (2004). 
The Middlesex University biokinetic model was developed to fit 
data collected for subject P, who was injected > 500 Bq 26Al-citrate 
and followed for + 10 years. 
Retention halftime (T1/2) of aluminium deposited in any organ or 
tissue is given in days.
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Figure 4. Pu(IV) biokinetics in mice: Tracer exchange in 
two-compartment system between blood plasma (P) and
interstitial water (I) with urinary excretion (EU).
Table A3: Kinetics of i.v. injected 238Pu(IV) citrate
in plasma and interstitial water of mice
Data from the literature
Durbin WP, Kullgren B and Schmidt CT: Circulatory kinetics of 
intravenously injected 238Pu(IV) citrate and 14C-CaNa3-DTPA in mice: 
Comparison with rat, dog and Reference Man. Health Physics  72 (2), 
222-235, 1997.
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Durbin WP, Kullgren B and Schmidt CT: Circulatory kinetics of intravenously injacted 238Pu(IV) citrate and 
14C-CaNa3-DTPA in mice: Comparison with rat, dog and Reference Man. Health Physics  72 (2), 222-235, 1997
Data from the literature
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Proposal of new action (Dietmar, Jutta):
• Refine the new physiological model, if necessary (e.g. skeleton/bones: Andrea?, all)
• Test the new physiological model (with data from the literature and from USTUR: all)
• Validation by comparing simulation and published experimental kinetic data (all)
• Further experiments needed? (all)
• Comparison with present models, e.g. Leggett et al. 2005 (all)
• Development of a final physiological model and discussion of its reliability and applicability (all)
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Finished…
Thank you for your attention.
The discussion is opened…
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Figures standby
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= Interstice/
interstitial fluid?
What is the meaning of Blood2/STO?
Plutonium distributes quickly to Blood 1 and Blood 2. These two 
blood compartments have no evident physiological basis in the 
biokinetic model. They represent two theoretically different forms 
of plutonium in the blood with different rates of urine excretion 
(R. W. Leggett, personal communication).
The Blood 1, Blood 2 and ST0 compartments are part of the 
extracellular fluid or, in Leggett’s words, ‘plutonium in 
circulation’. The soft tissue, STO (rapid turnover tissues), could 
represent extravascular fluid (R. W. Leggett, personal 
communication). Extravascular fluid may be interstitial fluid, 
because vascular is an anatomical term, meaning vessel (e.g. 
blood vessels and lymphatic vessels). 
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COMMON FEATURES
1. Blood 1 and Blood 2 represent two theoretically different forms of plutonium in the blood with different rates of urine excretion. 
In the aluminium model the blood serum and the adjacent interstice contain two different forms of aluminium. Physiologically, aluminium is in a 
kind of chemical equilibrium as a complex with citrate, a low-molecular molecule, and with transferrin, which is a high-molecular molecule. 
2. The biokinetic model for plutonium contains transfers from Blood 1 (thus physiologically corresponding to the blood serum) to the bones, to the 
liver (60% of activity), the digestive tract, the soft tissues (other soft tissues ST1 and 2), and the bladder. 
Both models also offer a possibility of transfer from the blood (blood serum and Blood 1, respectively) into the digestive tract and thus the 
possibility of metals being excreted from the body by way of the feces.
3. The Blood 1, Blood 2, and ST0 compartments are part of the extracellular fluid or, in Leggett’s words, “plutonium in circulation”. Circulating 
aluminium is contained in the blood vessels in the blood serum from where it enters the interstice (interstitial fluid). Physiologically, the 
interstice is the space between cell complexes typical of organs, which contains connective tissues, vessels, and nerves.
Leggett versus Schimmelpfeng
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DIFFERENCES
1. Biokinetic model for plutonium: the bone and liver compartments are “supplied” from Blood 1. 
Pharmacokinetic model for aluminium: blood serum only indirectly supplies the muscles and the bones through the interstice compartment.
2. Biokinetic model for plutonium: possibility of unilateral direct transfer of plutonium from the liver into the digestive tract. 
Pharmacokinetic model for aluminium: transfer possibility for the metal is bilateral, always passing through blood-serum.
3. Plutonium: can be transferred from Blood 1 to ST1 or ST2 (soft tissues). From ST1 or ST2, plutonium enters the Blood 2 compartment. 
Pharmacokinetic model: aluminium to and from the blood passes through interstice compartment into the muscle compartment. 
4. Biokinetic model: plutonium can be excreted through the bladder into the urine via Blood 1 and Blood 2. 
Pharmacokinetic model: for aluminium, there is only one transfer route from the blood serum to the urine.
5. Plutonium in circulation requires three compartments: from Blood 2 straight to Blood 1 or to ST0. From Blood 1 back to Blood 2 only indirectly 
via ST0, ST1 or ST2 (soft tissues). In case of aluminium, two compartments make up the extracellular fluid: aluminium can be transferred 
straight from blood to interstice and back. 
Fig. 3: Leggett versus Schimmelpfeng
Leggett versus Schimmelpfeng
